- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04763304
Self-contamination Following Removal of Two Personal Protective Equipment Suits: a Crossover Trial
Self-contamination Following Removal of Two Personal Protective Equipment Suits: a Randomized, Controlled, Crossover Simulation Trial
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Buenos Aires
-
Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina, 1199
- Hospital Italiano de Buenos Aires
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Anesthesiology Department member (Hospital Italiano de Buenos Aires, Buenos Aires, Argentina), participation in the PPE training workshop.
Exclusion Criteria:
- Refusal to participate in the study
- Known allergy to any of the components of the fluorescent lotion
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: PPE-G (gown) followed by PPE-C (coverall)
Placement of PPE-G (personal protective equipment including a gown for body protection) fluorescent solution full-body spray, removal of PPE-G and assessment of self-contamination through ultraviolet light scanning. Placement of PPE-C (personal protective equipment including a coverall for body protection), fluorescent solution full-body spray, removal of PPE-C and assessment of self-contamination through ultraviolet light scanning. |
Placement of PPE-G under direct instructions (audio recording), fluorescent solution full-body spray, removal of PPE under direct instructions (audio recording) and assessment of self-contamination through ultraviolet light scanning.
Active (wet wipe cleanse of any fluorescent traces visible under ultraviolet light scanning) and passive (15 minute interval) washout period to prevent a carry over effect on the second allocated intervention.
Placement of PPE-C under direct instructions (audio recording), fluorescent solution full-body spray, removal of PPE under direct instructions (audio recording) and assessment of self-contamination through ultraviolet light scanning.
Active (wet wipe cleanse of any fluorescent traces visible under ultraviolet light scanning) and passive (15 minute interval) washout period to prevent a carry over effect on the second allocated intervention.
|
Active Comparator: PPE-C (coverall) followed by PPE-G (gown)
Placement of PPE-C (personal protective equipment including a coverall for body protection), fluorescent solution full-body spray, removal of PPE-C and assessment of self-contamination through ultraviolet light scanning. Placement of PPE-G (personal protective equipment including a gown for body protection), fluorescent solution full-body spray, removal of PPE-G and assessment of self-contamination through ultraviolet light scanning. |
Placement of PPE-G under direct instructions (audio recording), fluorescent solution full-body spray, removal of PPE under direct instructions (audio recording) and assessment of self-contamination through ultraviolet light scanning.
Active (wet wipe cleanse of any fluorescent traces visible under ultraviolet light scanning) and passive (15 minute interval) washout period to prevent a carry over effect on the second allocated intervention.
Placement of PPE-C under direct instructions (audio recording), fluorescent solution full-body spray, removal of PPE under direct instructions (audio recording) and assessment of self-contamination through ultraviolet light scanning.
Active (wet wipe cleanse of any fluorescent traces visible under ultraviolet light scanning) and passive (15 minute interval) washout period to prevent a carry over effect on the second allocated intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean within-participant difference in self-contamination between PPE-G and PPE-C suits
Time Frame: 20 minutes
|
Mean difference between paired observations (number of fluorescent traces, any size, any body zone, per PPE suit) from each participant.
|
20 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between self-contamination and adherence to the PPE removal protocol
Time Frame: 5 minutes
|
Graphical illustration of adherence in the "X" axis and number of traces in the "Y" axis and calculation of the Spearman's rank-order correlation coefficient.
|
5 minutes
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 5646
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- Study Protocol
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Personal Protective Equipment
-
Virginia Commonwealth UniversityCompletedPersonal Protective EquipmentUnited States
-
University of Campinas, BrazilNot yet recruitingPersonal Protective Equipment
-
Kezban Aydan OkuyucuCompletedAirway Management | Personal Protective EquipmentTurkey
-
Brigham and Women's HospitalMemorial Sloan Kettering Cancer Center; Massachusetts General HospitalRecruitingPersonal Protective EquipmentUnited States
-
Bangkok Metropolitan Administration Medical College...Completed
-
Medical University of GrazCompletedPersonal Protective Equipment | Heat StressAustria
-
Hospital de Clinicas José de San MartínClaudio Yaryour; Fermepin Marcelo; Luis Sarotto; Federico Rodriguez Cairoli; Angela... and other collaboratorsUnknownVirus Diseases | SARS-CoV 2 | COVID | Health Personnel Attitude | rt PCR | Personal Protective Equipment PPE
-
University of VictoriaRecruitingInflammatory Response | Heat Stress, Exertional | Firefighter Personal Protective EquipmentCanada
-
University of the Balearic IslandsCompletedCovid19 | Personal Protective EquipmentSpain
-
University of OxfordCompletedCovid19 | Personal Protective EquipmentUnited Kingdom
Clinical Trials on Gown personal protective equipment (PPE-G) suit
-
Institute of Mountain Emergency MedicineCompletedCardiopulmonary Resuscitation | Personal Protective EquipmentItaly
-
University of Maryland, BaltimoreUniversity of Maryland, College ParkRecruiting
-
Medical University of GrazCompletedPersonal Protective Equipment | Heat StressAustria
-
University Medical Centre LjubljanaWithdrawn
-
An-Nan Hospital, China Medical UniversityCompleted
-
University of PadovaCompletedPneumothorax | Hemorrhage | Cardiac ArrestItaly
-
Federal State Budgetary Scientific Institution...CompletedOverheatingRussian Federation
-
Federal State Budgetary Scientific Institution...CompletedThermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 PatientsRussian Federation
-
Guy's and St Thomas' NHS Foundation TrustCompletedHealthyUnited Kingdom
-
Hospital Universitario San IgnacioPontificia Universidad Javeriana; Hospital Universitario Nacional de Colombia; Hospital de la Samaritana, Sede Bogotá y Sede Zipaquirá and other collaboratorsUnknownCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2